Panel - Applications and Challenges of MIDD in Nucleic Acid therapies

Panelist(s)

• 

  Xiao S. Hu, PhD

  President and Founder
  Translational Consulting, L.L.C.
  Chestnut Hill, Massachusetts, United States
• 

  Xiang Gao, PhD (he/him/his)

  VP, Head of Pharmacokinetics and Clinical Pharmacology
  Ionis Pharmaceuticals
  Vista, California, United States
• PZ

  Peijuan Zhu, PhD

  Senior Director, Clinical Pharmacology Lead
  Intellia Therapeutics, New Jersey, United States
• 

  Daniel Kirouac, PhD

  Vice President QSP
  Metrum Research Group, United States